Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), société de biopharmaceutique au stade clinique spécialisée dans le développement de médicaments innovants pour le traitement des urgences...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: This replaces the announcement made at 17:45 on October 31 because the following statement has been deleted: “The limited review procedures for the interim financial statements...
Repositionnement du glenzocimab dans le traitement de l’infarctus du myocarde avec élévation du segment ST (STEMI) Procédure de redressement judiciaire : prorogation de l'appel d'offres en vue...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.25 | 0.25 | 0.25 | 0 | 0 | DE |
4 | -0.079 | -24.0121580547 | 0.329 | 0.329 | 0.23 | 9728 | 0.27719758 | DE |
12 | -0.032 | -11.3475177305 | 0.282 | 0.89 | 0.22 | 55326 | 0.539616 | DE |
26 | -0.45 | -64.2857142857 | 0.7 | 0.89 | 0.22 | 31658 | 0.51783296 | DE |
52 | -2.63 | -91.3194444444 | 2.88 | 5.32 | 0.22 | 52091 | 1.0075129 | DE |
156 | -4.75 | -95 | 5 | 11 | 0.22 | 18910 | 1.5796381 | DE |
260 | 0.11 | 78.5714285714 | 0.14 | 11 | 0.14 | 59245 | 1.25483528 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約